Regeneron Pharmaceuticals (NQ: REGN )
814.99 +6.68 (+0.83%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2023 Add to My Watchlist
All News about Regeneron Pharmaceuticals
Are Gene Therapy Stocks The Market's Next Big Winners?
September 25, 2023
Biotechs Sarepta and BioMarin are among companies advancing cutting-edge gene therapies, although those treatments can come with a $2 million or more price.
Topics Artificial Intelligence
Exposures Artificial Intelligence
Regeneron Provides Update on Planned Chief Financial Officer Transition
September 08, 2023
Robert E. Landry to retire effective February 2024; Christopher Fenimore, long-standing Senior Vice President, Head of Accounting and Controller, to assume CFO role